Envestnet Asset Management
TAK icon

Envestnet Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

Envestnet Asset Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.6M Buy
1,598,174
+186,247
+13% +$3.08M 0.01% 1272
2026
Q1 		$26.1M Buy
1,411,927
+391,283
+38% +$6.87M 0.01% 1169
2025
Q4 		$15.9M Buy
1,020,644
+154,030
+18% +$2.2M ﹤0.01% 1368
2025
Q3 		$12.7M Sell
866,614
-13,260
-2% -$197K ﹤0.01% 1599
2025
Q2 		$13.6M Sell
879,874
-11,309
-1% -$167K ﹤0.01% 1529
2025
Q1 		$13.3M Sell
891,183
-93,495
-9% -$1.31M ﹤0.01% 1469
2024
Q4 		$13M Sell
984,678
-460,843
-32% -$6.33M ﹤0.01% 1468
2024
Q3 		$20.6M Sell
1,445,521
-37,972
-3% -$539K 0.01% 1170
2024
Q2 		$19.2M Sell
1,483,493
-45,894
-3% -$608K 0.01% 1151
2024
Q1 		$21.2M Sell
1,529,387
-59,426
-4% -$864K 0.01% 1071
2023
Q4 		$22.7M Buy
1,588,813
+75,877
+5% +$1.08M 0.01% 963
2023
Q3 		$23.4M Buy
1,512,936
+81,267
+6% +$1.26M 0.01% 891
2023
Q2 		$22.5M Sell
1,431,669
-3,267,934
-70% -$53.5M 0.01% 871
2023
Q1 		$19.3M Buy
4,699,603
+3,593,286
+325% +$57.2M 0.01% 902
2022
Q4 		$17.3M Buy
1,106,317
+216,445
+24% +$3.02M 0.01% 929
2022
Q3 		$11.5M Buy
889,872
+325,262
+58% +$4.52M 0.01% 1061
2022
Q2 		$7.93M Buy
564,610
+67,610
+14% +$965K ﹤0.01% 1278
2022
Q1 		$7.12M Buy
497,000
+68,166
+16% +$1M ﹤0.01% 1407
2021
Q4 		$5.84M Sell
428,834
-4,724
-1% -$66.3K ﹤0.01% 1508
2021
Q3 		$7.1M Buy
433,558
+21,600
+5% +$363K ﹤0.01% 1333
2021
Q2 		$6.93M Sell
411,958
-35,065
-8% -$597K ﹤0.01% 1328
2021
Q1 		$8.16M Buy
447,023
+18,607
+4% +$335K 0.01% 1164
2020
Q4 		$7.8M Buy
428,416
+68,397
+19% +$1.2M 0.01% 1043
2020
Q3 		$6.42M Buy
360,019
+250
+0.1% +$4.55K 0.01% 1031
2020
Q2 		$6.45M Buy
359,769
+4,234
+1% +$76K 0.01% 991
2020
Q1 		$5.4M Buy
355,535
+54,732
+18% +$992K 0.01% 955
2019
Q4 		$5.93M Buy
300,803
+18,967
+7% +$363K 0.01% 1041
2019
Q3 		$4.85M Buy
281,836
+28,318
+11% +$490K 0.01% 1083
2019
Q2 		$4.49M Buy
253,518
+55,187
+28% +$1M 0.01% 1111
2019
Q1 		$4.04M Buy
198,331
+87,781
+79% +$1.77M 0.01% 1117
2018
Q4 		$1.86M Buy
+110,550
New +$1.87M ﹤0.01% 1382

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Envestnet Asset Management's TAK Position: Q2 2026 in Review

Envestnet Asset Management increased its Takeda Pharmaceutical (TAK) stake by 13% in Q2 2026, buying an estimated $3.08M and bringing the position to 1,598,174 shares worth $25.6M. The position accounts for 0.01% of the portfolio, ranked #1272.

Envestnet Asset Management first reported a position in TAK in Q4 2018 and has held it in 31 quarters since. The position peaked at $26.1M in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Envestnet Asset Management held 1,598,174 shares of Takeda Pharmaceutical worth $25.6M as of Q2 2026.
  • Envestnet Asset Management bought 186,247 Takeda Pharmaceutical shares in Q2 2026, an estimated $3.08M.
  • Takeda Pharmaceutical made up 0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #1272 holding.
  • Envestnet Asset Management first reported a position in Takeda Pharmaceutical in Q4 2018 and has held it in 31 quarters since.
  • Envestnet Asset Management's Takeda Pharmaceutical position peaked at $26.1M in Q1 2026.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.